Compare HLLY & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLLY | CDXS |
|---|---|---|
| Founded | 1903 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.9M | 256.3M |
| IPO Year | 2020 | 2008 |
| Metric | HLLY | CDXS |
|---|---|---|
| Price | $3.05 | $1.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | 891.1K | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 180.00 | 43.82 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $613,514,000.00 | $138,590,000.00 |
| Revenue This Year | $6.32 | $7.73 |
| Revenue Next Year | $4.98 | $14.24 |
| P/E Ratio | $77.75 | ★ N/A |
| Revenue Growth | 1.87 | ★ 32.30 |
| 52 Week Low | $2.33 | $0.96 |
| 52 Week High | $4.48 | $3.06 |
| Indicator | HLLY | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 38.11 |
| Support Level | $2.76 | $1.38 |
| Resistance Level | $4.35 | $1.92 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 74.55 | 64.29 |
Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.